Home
About
Overview
Sharing Data
ORCID
Help
History (4)
A pilot, randomized, feasibility study to improve health self-management behaviors in older adults with multiple chronic conditions and functional limitations: Protocol for the Behavioral Activation and Occupational Therapy Trial (BA+OT).
Balantidium
Isorhapontigenin, a resveratrol analogue selectively inhibits ADP-stimulated platelet activation.
Operant conditioning of a multiple degree-of-freedom brain-machine interface in a primate model of amputation.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Isorhapontigenin, a resveratrol analogue selectively inhibits ADP-stimulated platelet activation.
Isorhapontigenin, a resveratrol analogue selectively inhibits ADP-stimulated platelet activation. Eur J Pharmacol. 2019 Nov 05; 862:172627.
View in:
PubMed
subject areas
Adenosine Diphosphate
Animals
Blood Platelets
Drug Evaluation, Preclinical
Female
Healthy Volunteers
Humans
Inhibitory Concentration 50
Male
Mice
Models, Animal
Molecular Docking Simulation
Platelet Aggregation
Platelet Aggregation Inhibitors
Platelet Function Tests
Platelet Glycoprotein GPIIb-IIIa Complex
Receptors, Purinergic P2Y12
Signal Transduction
Stilbenes
Thrombosis